{"filings":[{"id":99116,"accession_number":"0000832101-26-000012","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2026-05-08T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"IDEX shareholders elect 4 Class I directors, approve say-on-pay and auditor at 2026 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Mark A. Beck, Carl R. Christenson, Katrina L. Helmkamp, Alejandro Quiroz Centeno elected Class I directors (three-year terms).","Beck received 62,032,187 for; 4,324,559 against; 8,054 abstain. Christenson 63,045,254 for; 2,698,433 against; 621,113 abstain.","Helmkamp 64,809,672 for; 1,546,786 against; 8,342 abstain. Centeno 65,577,289 for; 778,817 against; 8,694 abstain.","Say-on-pay advisory vote approved: 58,071,019 affirmative, 7,464,627 negative, 829,154 abstentions.","Ratification of Deloitte & Touche as 2026 auditor approved: 58,038,340 for, 9,627,072 against, 5,230 abstain."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99115,"accession_number":"0000832101-26-000007","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2026-04-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IDEX Q1 adj. EPS $2.00 (+14% YoY); raises FY organic growth to 3-4% from 1-2%; record orders $988M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Sales $887M (+9% reported, +5% organic); record orders $988M (+13% reported, +10% organic).","Diluted EPS $1.61 (+28%); adjusted diluted EPS $2.00 (+14% YoY).","HST segment sales +17% (organic +11%) driven by AI/data center and semiconductor demand.","FY 2026 organic growth guidance raised to 3-4% (from 1-2%); adj. EPS guidance raised to $8.35-$8.55 from $8.15-$8.35.","Returned $129M to shareholders via $76M buybacks and $53M dividends in Q1."],"consensus_eps_estimate":null,"consensus_eps_actual":1.61,"consensus_revenue_estimate":null,"consensus_revenue_actual":886900000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114954,"accession_number":"0001193125-26-042918","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2026-02-09T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"IDEX eliminates position of SVP, Chief Strategy and Innovation Officer Roopa Unnikrishnan","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Roopa Unnikrishnan's position as SVP, Chief Strategy and Innovation Officer eliminated effective Feb 28, 2026.","Company expects to enter into a separation agreement per her existing letter agreement for termination without cause.","Ms. Unnikrishnan was a named executive officer in the Company's 2025 proxy statement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114953,"accession_number":"0001628280-26-005268","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2026-02-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IDEX Q4 record sales $899M (+4%), adjusted EPS $2.10 (+3%); FY 2026 guidance: adj. EPS $8.15-$8.35","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 sales $899M, +4% reported (+1% organic); record orders $979M, +20% reported (+16% organic).","Q4 diluted EPS $1.71 (+6%); adjusted diluted EPS $2.10 (+3%); full-year adj. EPS $7.95 (+1%).","Full-year operating cash flow $680M (+2%), free cash flow $617M (+2%), conversion 103% of net income.","2026 outlook: organic sales +1-2%, adj. diluted EPS $8.15-$8.35; Q1 adj. EPS $1.73-$1.78.","HST segment Q4 organic sales +5% (data center, semi); FSDP organic sales -5% on lower volumes."],"consensus_eps_estimate":null,"consensus_eps_actual":6.41,"consensus_revenue_estimate":null,"consensus_revenue_actual":3457500000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131344,"accession_number":"0001193125-25-308187","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2025-12-04T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"IDEX appoints Sean Gillen as CFO, effective Jan 5, 2026; CHRO Melissa Flores departing","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Sean Gillen named SVP & CFO, effective Jan 5, 2026; Akhil Mahendra returns to VP Corporate Development.","Gillen joins from AAR CORP. where he was CFO for nearly 7 years; previously VP & Treasurer at USG Corp.","Compensation: base salary $625k, target incentive 85%, annual equity LTIP $2M, sign-on $325k (12-month clawback), new hire RSU $3M vesting 1/3 annually.","Melissa Flores, SVP & CHRO, resigns effective Dec 19, 2025 to pursue another opportunity.","IDEX plans to externally fill CHRO role with focus on talent strategy; existing leadership to manage HR operations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131343,"accession_number":"0001628280-25-046909","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2025-10-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IDEX Q3 record sales $879M (+10% YoY); adj EPS $2.03 (+7%); narrows FY outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Record sales $879M (+10% reported, +5% organic); record orders $880M (+13% reported, +7% organic).","GAAP diluted EPS $1.70 (+8%); adjusted diluted EPS $2.03 (+7%).","Full year GAAP EPS narrowed to $6.35-$6.40; adj EPS $7.86-$7.91 (within prior range).","HST segment sales +22% (organic +10%); FSDP sales -3% (organic -5%); FMT +5% (organic +4%).","Repurchased $75M shares in Q3; increased buyback authorization to $1B; free cash flow $188.7M."],"consensus_eps_estimate":null,"consensus_eps_actual":4.7,"consensus_revenue_estimate":null,"consensus_revenue_actual":2558400000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":147916,"accession_number":"0000832101-25-000034","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2025-09-18T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"IDEX increases share repurchase authorization to $1B and declares $0.71 quarterly dividend","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Board authorized additional $635M share repurchase; total available now ~$1B including $365M remaining.","Regular quarterly cash dividend of $0.71 per share, payable Oct 24, 2025 to holders of record Oct 10.","CEO says IDEX expects to return at least 70% of free cash flow to shareholders in FY 2025.","IDEX repurchased over $100M in first half of 2025, accelerating buyback activity.","This marks the 124th consecutive regular quarterly cash dividend payment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":147915,"accession_number":"0000832101-25-000030","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2025-07-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IDEX Q2 record sales $865M (+7%); cuts FY adjusted EPS guidance to $7.85-$7.95","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 reported diluted EPS $1.74 (-6% YoY); adjusted EPS $2.07 (flat YoY), beating expectations.","Organic sales growth 1%; orders +7% reported (+2% organic); full-year organic growth forecast ~1%.","Guidance cut: FY 2025 adjusted EPS now $7.85-$7.95 (from $8.10-$8.45); Q3 adjusted EPS $1.90-$1.95.","Acquired Micro-LAM for ~$90M cash plus up to $12M earnout; complements optics technologies in HST.","Repurchased $50M in shares in May; repaid $100M 3.37% Senior Notes in June."],"consensus_eps_estimate":null,"consensus_eps_actual":3.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":1679700000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.78,"calibrated_materiality_score":0.78,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166638,"accession_number":"0001193125-25-123635","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2025-05-21T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"CFO Abhishek Khandelwal resigns; Akhil Mahendra named interim CFO effective May 30, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Abhishek Khandelwal resigns effective May 30, 2025, to pursue another opportunity; no disagreement with management or auditors.","Company retains external search firm for permanent CFO; appoints Akhil Mahendra as interim CFO starting May 30.","Mahendra, 44, is VP Corporate Development at IDEX; previously VP Corp Dev at Rivian and investment banker at Morgan Stanley.","Mahendra receives restricted stock award with $500,000 fair value, cliff vesting after three years."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166637,"accession_number":"0000832101-25-000020","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2025-05-12T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"IDEX Corporation annual meeting elects three directors; say-on-pay and auditor ratified; shareholder proposal fails","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Three Class III directors elected: Eric D. Ashleman (67.2M for), Stephanie J. Disher (64.4M for), Matthijs Glastra (66.2M for).","Advisory vote on executive compensation passed with 59.2M affirmative votes (86% of votes cast, excluding broker non-votes).","Ratification of Deloitte & Touche as auditor for 2025 approved with 60.6M affirmative votes (87% of votes cast).","Shareholder proposal on hiring practices related to arrest/incarceration records failed with only 9.4M affirmative votes (14.5% of votes cast)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166636,"accession_number":"0000832101-25-000015","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2025-05-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IDEX Q1 adjusted EPS $1.75, down 7% YoY; record orders $872M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Record orders $872M (+6% reported, +1% organic); sales $814M (+2% reported, -1% organic).","GAAP diluted EPS $1.26 (down 21%); adjusted EPS $1.75 (down 7%) on higher interest and tax.","FMT sales -7% (organic -4%); HST +10% (organic -1%); FSDP +4% (organic +5%).","Full-year guidance: GAAP EPS $6.56-$6.95; adjusted $8.10-$8.45; organic sales growth 1-3%.","Additional $20M cost actions for tariff mitigation; $50M share repurchase in Feb 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":1.26,"consensus_revenue_estimate":null,"consensus_revenue_actual":814300000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184056,"accession_number":"0000832101-25-000011","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2025-02-20T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"IDEX appoints two new directors; two directors to retire after 2025 annual meeting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Stephanie Disher (CEO of Atmus Filtration) and Matthijs Glastra (CEO of Novanta) join board effective Feb 21, 2025.","Board size increases from 10 to 12, will revert to 10 after the 2025 annual meeting when Parry and Satterthwaite retire.","David Parry and Livingston Satterthwaite will retire from the board after the 2025 Annual Meeting, not standing for re-election.","Disher will serve on Nominating and Corporate Governance Committee; Glastra on Audit Committee.","No familial relationships or related party transactions with IDEX disclosed for either new director."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184055,"accession_number":"0000832101-25-000005","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2025-02-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IDEX reports record Q4 sales of $863M (+9%), adjusted EPS up 11% to $2.04; guides 2025 adjusted EPS $8.10-$8.45","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 record sales $863M (+9% total, +3% organic); reported EPS $1.62 (+13%), adjusted EPS $2.04 (+11%).","Full year 2024 sales $3.3B (flat); reported EPS $6.64 (-15%), adjusted EPS $7.89 (-4%).","2025 outlook: organic sales +1% to +3%; GAAP EPS $6.56-$6.96, adjusted EPS $8.10-$8.45.","Q1 2025 guidance: organic sales -3% to -4%; GAAP EPS $1.18-$1.24, adjusted EPS $1.60-$1.65."],"consensus_eps_estimate":null,"consensus_eps_actual":6.64,"consensus_revenue_estimate":null,"consensus_revenue_actual":3268800000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200658,"accession_number":"0000832101-24-000053","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2024-10-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"IDEX Q3 adj EPS $1.90; sales flat organic; full-year GAAP EPS guidance lowered to $6.65-$6.70","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP diluted EPS $1.57 vs $2.75 prior year; adjusted diluted EPS $1.90 vs $2.12, down 10%.","Total sales $798M, up 1% as reported, flat organic; FMT +2%, HST -5%, FSDP +4% organic.","Completed Mott acquisition for ~$900M net (19x 2024 EBITDA); closed $500M 4.950% senior notes due 2029.","FY2024 guidance: organic sales decline 1-2%; GAAP EPS $6.65-$6.70 (down from $6.85-$6.95), adj EPS unchanged $7.85-$7.90.","Operating cash flow $205M (172% of net income); free cash flow $192M (133% of adj net income)."],"consensus_eps_estimate":null,"consensus_eps_actual":5.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":2405900000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216671,"accession_number":"0000832101-24-000047","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2024-09-05T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"IDEX completes acquisition of Mott Corporation, expanding material science capabilities","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquisition of Mott, leader in sintered porous materials and flow control, completed Sept 5, 2024.","Mott will operate within IDEX's Health & Science Technologies segment.","Expected to boost opportunities in semiconductor, energy transition, medical, space & defense, water.","Integration follows prior acquisitions: Muon Group, Iridian Spectral Technologies, STC Material Solutions.","IDEX plans to apply 8020 and IDEX Operating Model to drive value creation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216670,"accession_number":"0001193125-24-204531","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2024-08-21T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"IDEX issues $500M of 4.950% senior notes due 2029 to fund Mott acquisition","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $500M aggregate principal of 4.950% senior notes due September 1, 2029.","Net proceeds ~$495M after underwriting discount and expenses of ~$1.7M.","Proceeds plus credit facility and cash to fund the previously announced Mott Corporation acquisition.","Notes subject to special mandatory redemption at 101% if Mott deal not closed by November 20, 2024 or terminated.","Interest payable semi-annually on March 1 and September 1, commencing March 1, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216669,"accession_number":"0001193125-24-196415","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2024-08-08T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"IDEX issues $500M of 4.950% Senior Notes due 2029 to fund Mott acquisition","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Aggregate principal of $500.0M at 4.950% interest, maturing in 2029.","Underwriters include Wells Fargo, BofA Securities, and J.P. Morgan; closing expected August 21, 2024.","Net proceeds, with revolver borrowings and cash, will fund the cash consideration for the Mott Corporation acquisition.","Notes issued under existing indenture with Computershare Trust Company as trustee via Fifth Supplemental Indenture."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216668,"accession_number":"0000832101-24-000042","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2024-08-01T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"IDEX Q2 sales and profit miss; cuts full-year guidance; announces $1B Mott acquisition","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 sales $807M, down 5% (4% organic); GAAP EPS $1.86 (up 2%), adjusted EPS $2.06 (down 6%).","Full-year guidance cut: organic sales decline 1-2% (prior up 0-2%); GAAP EPS $6.85-$6.95, adjusted $7.80-$7.90.","Q3 guidance: organic sales flat to +1%; adjusted EPS $1.85-$1.90.","Announced $1.0B cash acquisition of Mott Corp, expected close Q3 2024.","Divested Alfa Valvole for $45.5M cash, recording a $4.6M gain."],"consensus_eps_estimate":null,"consensus_eps_actual":3.46,"consensus_revenue_estimate":null,"consensus_revenue_actual":1607700000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216667,"accession_number":"0000832101-24-000035","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2024-07-23T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"IDEX to acquire Mott Corporation for $1B cash to strengthen applied materials science capabilities","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Net transaction value ~$900M after $100M PV of expected tax benefits; 19x forecasted 2024 EBITDA (low-20s margin).","Mott expected to generate ~$200M revenue in 2024; deal expected to close by end of Q3 2024 subject to regulatory approvals.","Transaction expected to be accretive to adjusted EPS in fiscal 2026; funded via cash, credit facility, and potential debt.","Mott will join IDEX Health & Science Technologies segment; adds semiconductor, energy transition, medtech, and space/defense exposure.","IDEX expects synergies through 80/20 operating model and commercial growth over three years."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236343,"accession_number":"0000832101-24-000018","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2024-05-08T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"IDEX annual meeting: all management proposals approved; shareholder proposal on hiring rejected","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Class II directors Buthman, Gunter, and Watts-Stanfield re-elected with 60M-68M votes each.","Advisory say-on-pay passed with 61.8M affirmative (5.9M negative).","IDEX 2024 Incentive Award Plan approved with 62.3M votes for, 5.4M against.","Ratification of Deloitte as auditor for 2024 passed with 63.1M votes for, 7.0M against.","Shareholder proposal on hiring practices related to arrest/incarceration records defeated (11.1M for, 54.9M against)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236342,"accession_number":"0000832101-24-000013","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2024-04-24T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"IDEX Q1 sales $801M, -6% organic; adj. EPS $1.88 beats; FY guidance held","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Reported diluted EPS $1.60 (-13% YoY); adjusted EPS $1.88 (-10%), above expectations.","Organic sales -6% driven by HST segment (-13%); FMT -3%, FSDP +2%.","Operating cash flow $157M (+6%); free cash flow $137M (+13%).","FY2024 outlook: organic sales 0-2% growth; GAAP EPS $7.13-$7.43; adjusted $8.15-$8.45.","Q2 guidance: organic sales -2% to -3%; adjusted EPS $2.00-$2.05."],"consensus_eps_estimate":null,"consensus_eps_actual":1.6,"consensus_revenue_estimate":null,"consensus_revenue_actual":800500000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":254008,"accession_number":"0000832101-24-000004","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2024-02-07T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"IDEX Q4 sales -3%, adjusted EPS $1.83 (-9% YoY); FY2024 adjusted EPS guidance $8.15-$8.45","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 sales $789M (-3%, -6% organic); GAAP EPS $1.43 (-16%), adjusted EPS $1.83 (-9%).","Full-year record sales $3.3B, record adjusted EPS $8.22 (+1%), record free cash flow $627M.","HST segment sales -11% YoY (-19% organic); adjusted EBITDA margin 25.8% (-450bps) on weak Life Sciences.","Acquired STC Material Solutions for $202M in Dec 2023; divested Novotema with $9.1M loss.","FY2024 outlook: organic sales growth 0-2%, GAAP EPS $7.15-$7.45, adjusted EPS $8.15-$8.45."],"consensus_eps_estimate":null,"consensus_eps_actual":7.85,"consensus_revenue_estimate":null,"consensus_revenue_actual":3273900000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":271483,"accession_number":"0000832101-23-000047","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2023-10-26T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"IDEX Q3 adjusted EPS $2.12, revenue $793M; raises FY EPS guidance to $8.13-$8.18","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 net sales $793.4M, down 4% (-6% organic); diluted GAAP EPS $2.75, up 17% YoY.","Adjusted diluted EPS $2.12, down 1% YoY; adjusted EBITDA margin 28.4%, down 30 bps.","Raises FY 2023 GAAP EPS guidance to $7.91-$7.96 and adjusted EPS to $8.13-$8.18.","Record free cash flow $207M, up 14% YoY; operating cash flow $227M.","Completed sale of Micropump for $110M cash, pre-tax gain $93.8M; repaid $150M debt."],"consensus_eps_estimate":null,"consensus_eps_actual":6.42,"consensus_revenue_estimate":null,"consensus_revenue_actual":2485000000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":271482,"accession_number":"0000832101-23-000044","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2023-10-25T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"IDEX appoints Abhi Khandelwal as CFO effective Nov 20, 2023","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Khandelwal, former IDEX VP (2010-2020), returns from Multi-Color Corp CFO role.","He receives $575K base salary, 75% target bonus, $1.3M annual equity, $2M new hire equity, $300K sign-on.","Allison Lausas steps down as interim CFO, continues as VP and Chief Accounting Officer.","Severance: 12 months base+bonus without cause; double under change in control within 24 months.","No family relationships or related transactions; subject to non-compete and non-solicit."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":288346,"accession_number":"0000832101-23-000038","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2023-08-30T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"IDEX eliminates position of SVP Group Executive Health & Science Technologies","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Marc Uleman's role eliminated effective September 11, 2023, due to internal reorganization.","Mr. Uleman will no longer serve in an executive role at IDEX.","No successor has been named for the eliminated position."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":288345,"accession_number":"0000832101-23-000037","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2023-08-30T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"IDEX CFO William Grogan resigns; Allison Lausas appointed interim CFO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["William K. Grogan resigns as SVP & CFO effective Sept 15, 2023, to pursue new opportunity; departure not due to any disagreement.","Allison S. Lausas, VP & Chief Accounting Officer, appointed interim CFO; she will also retain the CAO role.","Compensation Committee awarded Lausas 2,200 shares of restricted stock, cliff vesting after three years.","Company has begun search for permanent CFO, considering internal and external candidates."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":288344,"accession_number":"0000832101-23-000032","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2023-07-27T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"IDEX reports record Q2 sales $846M; lowers FY adjusted EPS guidance to $7.90-$8.00 on HST weakness","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Record Q2 sales $846.2M (+6% overall, +3% organic); reported EPS $1.82, adj. EPS $2.18 (+8%).","FY2023 guidance lowered: organic sales decline 1-2%, GAAP EPS $6.80-$6.90, adj. EPS $7.90-$8.00.","HST segment organic sales -6%, Adj. EBITDA margin -420bps to 27.6%; CEO sees no H2 recovery.","Completed Iridian acquisition for $110.3M cash; issued $100M 5.13% senior notes due 2028.","Operating cash flow $141.2M (+26%), free cash flow $119.6M (+24%)."],"consensus_eps_estimate":null,"consensus_eps_actual":3.66,"consensus_revenue_estimate":null,"consensus_revenue_actual":1691600000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":308823,"accession_number":"0000832101-23-000027","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2023-06-14T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"IDEX issues $100M 5.13% senior notes due 2028 to refinance maturing notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $100M aggregate principal of 5.13% Series C Senior Notes due June 13, 2028.","Proceeds used to repay $100M of 3.20% Series A Senior Notes due June 13, 2023.","Established a shelf facility with NYL Investors for up to $300M in additional notes through June 2026.","Notes are unsecured, rank pari passu with other unsecured unsubordinated debt.","Covenants include leverage, interest coverage and priority debt ratios; customary events of default."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":308822,"accession_number":"0000832101-23-000022","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2023-05-31T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"IDEX shareholders elect all four Class I director nominees, approve say-on-pay","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Katrina L. Helmkamp, Mark A. Beck, Carl R. Christenson, Alejandro Quiroz Centeno elected as Class I directors.","Advisory vote on executive compensation passed with 65.3M affirmative vs 3.6M negative.","Stockholders voted for an advisory vote every one year; board adopted annual frequency.","Ratification of Deloitte & Touche as auditor for 2023 approved with 67.1M votes.","Stockholder proposal on hiring practices related to arrest/incarceration records failed with 12.6M for, 55.6M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":308821,"accession_number":"0000832101-23-000017","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2023-04-27T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"IDEX records Q1 sales record, cuts FY2023 adj. EPS guidance amid HST inventory correction; announces acquisition","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Record Q1 sales $845M (+13% YoY); reported EPS $1.84, adjusted EPS $2.09 (+7% vs $1.96).","Health & Science Technologies inventory correction larger than expected; full-year adjusted EPS guidance lowered to $8.25–$8.55.","Agreed to acquire Iridian Spectral Technologies for CAD$150M; expected to close Q2 2023.","Operating cash flow $148M (+86% YoY); free cash flow $121M (+91%).","FMT segment margin up 50bps to 33.0%, FSDP up 160bps to 28.5%, HST down 300bps to 28.7%."],"consensus_eps_estimate":null,"consensus_eps_actual":1.84,"consensus_revenue_estimate":null,"consensus_revenue_actual":845400000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":327607,"accession_number":"0000832101-23-000004","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2023-02-01T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"IDEX reports record 2022 EPS of $7.71; guides 2023 adj. EPS $8.50-$8.80","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $810.7M (+13%), adj. EPS $2.01 (+18%); FY rev $3.18B (+15%), adj. EPS $8.12 (+18%)","Record 2022 orders $3.3B, sales $3.2B; invested >$1B in acquisitions, capex, and share repurchases","Acquired Muon Group for $713M (Nov 2022); sold Knight for $49.4M (Sep 2022) gaining $34.8M pre-tax","2023 guidance: organic sales growth 1-5%; adj. EPS $8.50-$8.80; Q1 adj. EPS $1.98-$2.03","Segment margins: FMT 30.0% (+180bps), HST 30.3% (-150bps), FSDP 27.3% (-90bps)"],"consensus_eps_estimate":null,"consensus_eps_actual":7.71,"consensus_revenue_estimate":null,"consensus_revenue_actual":3181900000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":345304,"accession_number":"0000832101-22-000066","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2022-12-16T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"IDEX changes segment profit measure from operating income to Adjusted EBITDA effective Q4 2022","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["New measure is Adjusted EBITDA, defined as EBITDA before certain non-recurring items; effective quarter ending Dec 31, 2022.","Change aligns with how CODM allocates resources and evaluates business performance, per ASC 280.","Does not revise any previously reported consolidated financial statements; restated segment data for 2021 and 2022 furnished in Exhibit 99.1.","Adjusted EBITDA adjustments include fair value step-up, restructuring, asset impairments, pension termination, and COVID-19 testing exit."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":345303,"accession_number":"0000832101-22-000063","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2022-11-18T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"IDEX completes acquisition of Muon Group, micro-precision tech firm","summary_kind":"llm","event_type":"m_and_a","confidence":"medium","bullets":["Acquisition of Muon B.V. and subsidiaries closed on November 18, 2022.","Muon Group includes LouwersHanique, Veco, Millux, Tecan, and Atul, all focused on high-precision flow paths.","Muon Group will report into IDEX's Health & Science Technology (HST) segment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":345302,"accession_number":"0000832101-22-000061","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2022-11-17T23:59:59+00:00","items":["2.03","9.01"],"status":"ready","headline":"IDEX draws $368M in credit facilities to fund Muon B.V. acquisition","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Drew $200M from term credit facility on Nov 10, 2022.","Drew approx $168M from revolving credit facility on Nov 10 and Nov 15, 2022.","Borrowings under Credit Agreement mature Nov 1, 2027; interest based on base rate or Term SOFR plus margin.","Proceeds used to finance portion of consideration for previously announced acquisition of Muon B.V.","Credit Agreement filed as Exhibit 10.1 to Nov 2, 2022 8-K."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":345301,"accession_number":"0000832101-22-000059","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2022-11-02T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"IDEX amends credit agreement to $800M revolver, adds $200M term loan for Muon acquisition","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Revolving credit facility increased to $800M with maturity extended to November 1, 2027.","New $200M term loan facility available until March 3, 2023, to fund portion of Muon Group B.V. acquisition.","Up to $100M letters of credit and $50M swing line loans; option to increase commitments by up to $400M.","Interest based on base rate or Term SOFR plus margin tied to debt rating/leverage ratio; ESG pricing adjustment possible.","Financial covenants include interest coverage and leverage ratios, tested quarterly."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":345300,"accession_number":"0000832101-22-000054","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2022-10-26T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"IDEX Q3 record EPS $2.36 (adjusted $2.14), sales $824M +16%, raises FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Record Q3 sales $824M (+16% overall, +15% organic YoY); operating margin 24.5% (adj. 24.9%).","Record EPS $2.36 (adj. $2.14), up 56%/20% YoY; cash from ops $198M, free cash flow $182M.","FY2022 guidance raised: GAAP EPS $7.75–$7.80, adj. EPS $8.04–$8.09; organic sales growth ~12%.","Acquired Muon Group for €700M (closing expected Q4 2022); completed sale of Knight for $49.4M.","Exited COVID-19 testing application: $16.8M impairment, $17.9M deferred revenue acceleration (net $1.1M)."],"consensus_eps_estimate":null,"consensus_eps_actual":6.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":2371200000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":361758,"accession_number":"0000832101-22-000051","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2022-09-22T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"IDEX appoints Katrina Helmkamp as Non-Executive Chair, William Cook retires","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["William M. Cook retires as director and Non-Executive Chairman effective October 1, 2022; no disagreement cited.","Katrina L. Helmkamp appointed Non-Executive Chair, effective October 1, 2022; she joined the board in November 2015.","Board size reduces from 11 to 10 directors upon Cook's departure.","Helmkamp is President and CEO of Cartus Corp. and previously CEO of Lenox Corp. and VP at Whirlpool."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":361757,"accession_number":"0000832101-22-000049","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2022-09-13T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"IDEX acquires Muon Group for €700M to expand precision tech platform","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["All-cash deal valued at €700 million; expected close in Q4 2022 subject to regulatory approvals.","Muon expected FY2022 sales ~€140 million with EBITDA margins of ~33%.","Acquisition funded by cash on hand and IDEX's revolving credit facility.","Muon will join IDEX's Health & Science Technology segment (Scientific Fluidics & Optics group).","Muon Group privately held by Rivean Capital; includes brands LouwersHanique, Veco, Millux, Tecan, Atul."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":361756,"accession_number":"0000832101-22-000038","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2022-07-27T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"IDEX Q2 EPS $1.81 beats; adjusted EPS $2.02; raises FY22 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP EPS $1.81 (up 35% YoY); adjusted EPS $2.02 (up 15%); revenue $796M (+16% overall, +12% organic).","FY22 GAAP EPS guidance raised to $7.19-$7.29 from $6.87-$7.00; adjusted EPS raised to $7.88-$7.98 from $7.50-$7.63.","Acquired KZValve for $120.2M cash on May 2, 2022, expanding agricultural fluid management portfolio.","Repurchased 475K shares in Q2; dividend increased 11%.","Segment: FMT operating margin 27.7% (+240bps); HST 26.5% (-110bps); Fire/Safety 23.3% (-330bps)."],"consensus_eps_estimate":null,"consensus_eps_actual":3.65,"consensus_revenue_estimate":null,"consensus_revenue_actual":1547200000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":381170,"accession_number":"0000832101-22-000033","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2022-06-16T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"IDEX appoints Alejandro Quiroz Centeno to Board effective June 15, 2022","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Alejandro Quiroz Centeno appointed to IDEX Board effective June 15, 2022, increasing board size from 10 to 11; will serve on Compensation Committee.","Mr. Quiroz is CEO Latin America for Prysmian Group, a global energy and telecom cable systems leader.","Previously President of Aptiv Latin America, leading a $5.5B automotive technology business with 75,000 employees.","CEO Eric Ashleman noted Quiroz's experience leading international manufacturing organizations will benefit IDEX, now over 50% revenue from outside U.S.","Board Chairman William Cook said Quiroz's global business experience will bring great value to the board."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":381169,"accession_number":"0000832101-22-000018","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2022-05-10T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Ernest Mrozek retires from IDEX board; four directors elected at annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Ernest J. Mrozek retired from the Board following the May 6, 2022 annual meeting; board size fixed at ten.","Shareholders elected Livingston Satterthwaite, David Parry, Eric Ashleman as Class III directors (three-year terms).","L. Paris Watts-Stanfield elected as Class II director for a two-year term expiring in 2024.","Advisory vote on executive compensation approved: ~68M for, ~5.5M against, 38K abstentions.","Ratification of Deloitte & Touche as independent auditor for 2022 passed with ~66.3M affirmative votes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":381168,"accession_number":"0000832101-22-000014","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2022-04-27T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"IDEX reports record Q1 EPS $1.83 (adj. $1.96); sales $751M +15% YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Record reported EPS $1.83, up 24% YoY; adjusted EPS $1.96, up 21% vs. Q1 2021.","Record sales $751M, +15% overall (+12% organic); orders $856M, +20% (+16% organic).","Operating margin 25.0% (+110bps); adjusted EBITDA margin 28.6% (+90bps).","Completed Nexsight acquisition ($114.7M) on Feb 28; announced KZValve deal ($120M), expected close Q2 2022.","FY 2022 guidance: organic sales growth 6-8%; adjusted EPS $7.50-$7.63. Q2: adj. EPS $1.85-$1.90."],"consensus_eps_estimate":null,"consensus_eps_actual":1.83,"consensus_revenue_estimate":null,"consensus_revenue_actual":751100000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":399202,"accession_number":"0000832101-22-000010","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2022-02-28T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"IDEX appoints Paris Watts-Stanfield to Board, effective Feb 25, 2022","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Paris Watts-Stanfield appointed as director, effective February 25, 2022; board expands from 10 to 11 members.","She will serve on the Audit Committee; is VP & CFO Greater China at Medtronic.","Background includes corporate finance roles at Medtronic, Alcoa, Walmart, and Procter & Gamble.","Appointment supports IDEX's growth and ESG commitments per Chairman William Cook."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":399201,"accession_number":"0000832101-22-000004","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2022-02-08T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"IDEX Corp GC Denise R. Cade resigns effective Feb 25, 2022","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Denise R. Cade to step down as SVP, General Counsel and Corporate Secretary on Feb 25, 2022.","Resignation due to pursuit of another employment opportunity.","No successor announced; CFO William K. Grogan signed the 8-K."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":399200,"accession_number":"0000832101-22-000002","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2022-02-02T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"IDEX reports record Q4 EPS $1.55, full-year EPS $5.88; acquires Nexsight for $120M; guides FY22 adj EPS $7.33-$7.63","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Record Q4 EPS $1.55 on sales $714.8M (+16% overall, +11% organic vs Q4 2020); full year EPS $5.88 (+19%).","Full year sales $2.8B (+18%); adjusted EPS $6.30 (+21%); record Q4 orders $795.3M (+17%).","Acquired Nexsight (Envirosight, WinCan, MyTana, Pipeline Renewal Technologies) for $120M cash; expected close Q1 2022.","FY22 guidance: organic sales growth 5-8%; GAAP EPS $6.70-$7.00, adjusted EPS $7.33-$7.63 under revised definition.","Health & Science Technologies led with Q4 sales +25% (+16% organic); segment margin up 210 bps to 25.8%."],"consensus_eps_estimate":null,"consensus_eps_actual":5.88,"consensus_revenue_estimate":null,"consensus_revenue_actual":2764800000.0,"consensus_period":"2021-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":418184,"accession_number":"0000832101-21-000058","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2021-10-27T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"IDEX Q3 2021: record sales $712M, EPS $1.51; adjusted EPS $1.63; raises FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Record orders $774.2M (+36% overall, +28% organic); record sales $712.0M (+23%, +15% organic).","Reported EPS $1.51; adjusted EPS $1.63 (record), up 16.4% YoY on adjusted basis.","Adjusted operating margin 24.3% (+120 bps); adjusted gross margin 45.0% (+170 bps).","FY2021 adjusted EPS guidance narrowed to $6.30-$6.33 from $6.26-$6.36.","Health & Science sales +37% (+24% organic); Fire & Safety +13% (+12% organic)."],"consensus_eps_estimate":null,"consensus_eps_actual":4.33,"consensus_revenue_estimate":null,"consensus_revenue_actual":2050002000.0,"consensus_period":"2021-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":435739,"accession_number":"0000832101-21-000055","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2021-08-26T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"IDEX appoints Allison Lausas as Chief Accounting Officer effective immediately","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Lausas served as interim CFO of SunCoke Energy (Apr-Jul 2021), Treasurer since Jul 2019, and VP/Controller since May 2018.","Base salary $375,000; target bonus 50% of base under MICP; eligible for annual equity awards targeting $200,000.","Sign-on: $130,000 cash bonus and $450,000 equity award split equally between stock options and restricted stock.","Options vest 25% annually; restricted stock vests 100% on third anniversary; subject to continued employment.","No family relationships with directors/officers and no transactions requiring disclosure under Item 404(a)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":435738,"accession_number":"0000832101-21-000050","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2021-07-28T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"IDEX reports record Q2 sales and orders; raises full-year adjusted EPS guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Record orders $751.0M (+44% overall, +39% organic) and record sales $685.9M (+22% overall, +17% organic).","Reported EPS $1.34; adjusted EPS $1.61, up 46.4% YoY. Adjusted operating margin 24.4% (+330 bps).","Full-year adjusted EPS guidance raised to $6.26-$6.36 from $6.05-$6.20; Q3 adjusted EPS seen $1.57-$1.61.","Closed Airtech acquisition for ~$469M; refinanced $350M 4.2% notes to $500M 2.625% notes due 2031.","Terminated U.S. pension plan, recognizing $9.7M noncash loss; quarterly dividend raised 8% to $0.54."],"consensus_eps_estimate":null,"consensus_eps_actual":2.81,"consensus_revenue_estimate":null,"consensus_revenue_actual":1337983000.0,"consensus_period":"2021-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":435737,"accession_number":"0000832101-21-000047","cik":832101,"company_name":"IDEX CORP /DE/","ticker":"IEX","form_type":"8-K","filed_at":"2021-07-02T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"IDEX Corp Senior VP of Corporate Development Daniel J. Salliotte to depart by March 1, 2022","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Separation agreed on June 17; Mr. Salliotte remains until March 1, 2022, providing transition services.","He continues base salary and medical benefits until separation date.","Post-separation lump sum: $31,616 for medical coverage plus base salary and target bonus severance per 2010 offer letter.","Severance agreement includes a general release and waiver."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":15672687791.794155,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}